Article Details
Retrieved on: 2024-09-07 03:48:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In a report released today, Carter Gould from Barclays assigned a Buy rating to Vor Biopharma (VOR – Research Report), with a price target...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here